Integrated Proteins Ltd - 519606 - Board Meeting Outcome for Revised Outcome For The Quarter And Year Ended March 31,2026.
Integrated Proteins revised its audited financial results for FY26. Net profit decreased to Rs. 19.00 lakhs from Rs. 23.14 lakhs, and EPS to Rs. 0.10 from Rs. 0.13, following an oversight in taxation provision.
May 27 2026 20:12:59
Integrated Proteins Ltd - 519606 - Board Meeting Outcome for The Board Has Considered And Approved The Financials For The Quarter And Year Ended March 31,2026
Integrated Proteins board approved its Audited Financial Results for the financial year ended March 31, 2026. The company reported a revenue of ₹21.53 crores and a net profit of ₹0.23 crores for FY26, with an EPS of ₹0.12.
May 26 2026 19:53:36
Integrated Proteins Ltd - 519606 - Board Meeting Intimation for Postponement And Rescheduling Of Board Meeting.
Integrated Proteins' board meeting to consider and approve standalone audited financial results for Q4 and FY ended March 31, 2026, has been postponed from May 23, 2026, to May 26, 2026, due to unavoidable circumstances.
May 23 2026 22:44:35
Integrated Proteins Ltd - 519606 - Board Meeting Intimation for Audited Standalone Financial Results For The Quarter And Year Ended March 31 , 2026.
Integrated Proteins' Board of Directors is scheduled to meet on May 23, 2026. The primary agenda is to consider and approve the audited standalone financial results for the quarter and year ended March 31, 2026.
May 20 2026 22:22:52
Read More